On July 15, 2025, NICE responded that Northwest Biotherapeutics was “not yet in a position to submit” its evidence package...So if that letter from NICE is genuine, and there’s no reason to believe it’s not, it places NWBO in exactly the post-opinion, pre-announcement window. This is the formal administrative step where the MHRA drafts the legal label (SmPC), which NICE needs before it can accept the application. It’s procedural, not speculative.
Except that in September of 2018 NICE confirmed the same exact thing.
9 September 2018: The company has informed NICE that, at this time, it cannot provide an evidence submission that is required for this appraisal. Therefore, we are suspending the appraisal while we hold further discussions with the company. We will provide a further update and rescheduled timelines in due course
Are you trying to tell me that NWBO has been in the "labeling phase" for 7 years?
You are unintelligent, uninformed, abusing AI, misleading investors, and quite frankly what you are doing is illegal. You cannot present this information as "factual". It is nothing but far fetched fabrications and speculation. You need to stop.
Market Data 
Markets 
